Credit Suisse Downgrades GoHealth to Neutral, Lowers Price Target to $10
Credit Suisse analyst Jailendra Singh downgrades GoHealth (NASDAQ:GOCO) from Outperform to Neutral and lowers the price target from $18 to $10.
Uncategorized
urgan-gro CEO Highlights One Of The New Segments Co. Targeting Is ‘Crop Agnostic’
https://www.youtube.com/watch?v=oqcBAxa4o5o
Related Posts
Here’s Why Warner Bros. Discovery Shares Are Seeing Blue Skies Friday
Warner Bros. Discovery Inc (NASDAQ: WBD) shares are trading higher by 3.49% to $12.90 during Friday's session. Shares of several companies with streaming exposure, including Warner Bros.
Blucora Q2 EPS $1.28 Beats $1.14 Estimate, Sales $254.30M Beat $252.00M Estimate
Blucora (NASDAQ:BCOR) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.14 by 12.28 percent. This is a 1322.22 percent increase over earnings of $0.09 per share from the same